Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
TriSalus Life Sciences (TLSI)
NASDAQ:TLSI
RESEARCH TOOLSreports
Holding TLSI?
Track your performance easily
Earnings Data
Report Date
Apr 07, 2025TBA Not Confirmed
Period Ending
2024 (Q4)Consensus EPS Forecast
-0.31Last Year’s EPS
-0.6Same Quarter Last Year
Strong Buy
Based on 6 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Apr 01, 2024
|% Change Since: 6.22%
|Next Earnings Date:Nov 14, 2023
Earnings Call Sentiment|Positive
TriSalus Life Sciences shows strong revenue growth and operational improvements with significant product launches and market opportunities. However, the company faces challenges with cash flow management and dependency on future partnerships for further advancements.Company Guidance
During the third quarter of 2024 earnings call, TriSalus Life Sciences provided forward-looking guidance, projecting over 50% annual revenue growth driven by the expansion of their market footprint and innovative product launches. The company reported Q3 revenue of $7.3 million, marking a 42% increase compared to the previous year. Key growth drivers include new account activations, increased penetration in existing accounts, and the effective use of TriNav in complex patient treatments. TriSalus aims to expand its commercial team to about 50 personnel by year-end to enhance coverage in high-procedure markets. The launch of TriNav Large and the upcoming TriNav 2.0 in 2025 are expected to further bolster market penetration. The company is also focusing on reducing expenses and achieving EBITDA positivity by 2025, with anticipated declines in operating expenses by 20% due to diminishing clinical costs and general administrative expenses.Strong Revenue Growth
TriSalus reported a total revenue of $7.3 million for Q3 2024, reflecting a 42% growth compared to the same period in 2023. Year-to-date revenue stands at $21.2 million, reflecting a 66% growth compared to the first 9 months of last year.
High Gross Margin
The company maintained a robust gross margin of 86% in Q3 2024, consistent with year-to-date margin and up from 84% for the 9-month period in 2023.
Innovative Product Launches
Launch of TriNav Large and TriGuide Catheter is underway, addressing embolization challenges and extending the TriNav product portfolio.
Cost Reductions and Improved Financials
R&D expenses down 56% in Q3 and operating losses reduced to negative $8.7 million from $18.8 million in the same quarter of 2023.
Significant Market Opportunity
Market opportunity for TriNav technology is now over $1 billion with the inclusion of multinodular goiter treatment.
Positive Clinical Trial Results
Encouraging results from PERIO-01 trial suggest that nelitolimod administered via PEDD can enhance the therapeutic impact of immune checkpoint inhibitors.
---
TLSI Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
TLSI Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Nov 14, 2024 | $4.50 | $4.01 | -10.89% |
| Aug 15, 2024 | $5.85 | $5.89 | +0.68% |
| May 15, 2024 | $10.15 | $9.39 | -7.49% |
| Apr 01, 2024 | $9.75 | $10.25 | +5.13% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does TriSalus Life Sciences (TLSI) report earnings?
TriSalus Life Sciences (TLSI) is schdueled to report earning on Apr 07, 2025, TBA Not Confirmed.
What is TriSalus Life Sciences (TLSI) earnings time?
TriSalus Life Sciences (TLSI) earnings time is at Apr 07, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is TLSI EPS forecast?
TLSI EPS forecast for the fiscal quarter 2024 (Q4) is -0.31.
---